psych- not in EH's cards Flashcards
failure to taper down antidepressants will result in this syndrome
withdrawal syndrome w FINISH sx
flu like sx, insomnia, nausea, imbalance, sensory changes, hyperarousal
which two SSRIs have dual MOAs
V for 2
Vilazodone= SSRI and partial agonist of 5HT1A Vortioxetine= SSRI and partial agonist of 5HT1B and full antagonist of 5HT1A,D,3-7
sx of serotonin syndrome
sweating, hyperreflexia, myoclonus, shivering/tremors
SSRIs w LEAST cyp450 interaction
escitalopram
vortioxetine
describe receptor sensitivity of different types of SNRIs
NON-TCA= 5HT > NE
3 amines= mostly equal (except A+C act like non-TCA)
2 amines= NE> 5HT
AEs of trazodone
= SARA
sedation and orthostatic hypotension
priapism
AEs of mirtazapine
sedation and weight gain
bupropion
nicotine withdrawal
antidepressant
trx ADHD sx (inattentiveness)
MOA of MAO-I
MAO breaks down NE, 5HT, DA so we stop that
what are the MAO inhibitors
isocarboxazid
phenelizine
selegiline
tranylcypromine
what is the only indication for fluoxemine
OCD
imipramine special indication
enuresis = bed wetting
which two antidepressants work with DA
amoxipine and bupropion
MOA of nefazodone and trazodone
antagonize SERT presynpatically
postsynaptically antagonize a1 (on NE neurons) and 5HT2
MOA of mirtazepan
presynaptic block a2, postsynaptic 5HT2
MOA of bupripion
block NET and D2 receptors
agonist VMAT2
=an NDRI
pharmokinetics +dynamics of MAO inhibitors
=nonselective except selegilline (MAO-B selective, is a patch so least sideeffects bc not systemically absorbed)
oral agents are irreversible, takes 14 days for MAO to regenerate
how to prevent serotonin syndrome w MAO inhibitors
titrate off MAO inhibitors before starting other serotonin syndrome
for 2 weeks
4 weeks for fluoxetine
due to MAO-A making tyramine, so less risk for sergelline
dont eat foods w high tyramine (picked and cheeses)
esketamine indication
treatment resistant depression, give nasally
highly addictive,
observe for 2 hours after you give it, by checking BP
Brexanolone
MOA and indication and how is it delivered
GABA(A) receptor modulator
used for postpartum depression
60 hour IV admission, lasts for 30 days
what mood stabilizer is considered neuroprotective
and in what part of the pbrain
lithium
hippocampus, anterior cingulate cortex, superior temporal gyrus, ventral prefrontal cortex
explain the effect of lithium function at different receptors
inhib D2 (Gs and Gi) --> trx mania inhibit NMDA receptor--> glutamate modulation
promote GABA R–> GABA release
MOA of benzos
allosteric modification of GABA A receptors–> increased Cl influx–> CNS inhibition
indication for benzos
short term insomnia (tho associated w lots of AEs+dependence)
parasomnias in children (sleepwalking/night terrors)
sk M relaxation
IV administration for status epilepticus, seizures, sedation and anesthesia
withdrawal from alc/drugs
AEs of benzos
tolerance (down-regulation of GABA A)
physical dependence
dose related CNS depression and decreased memory
central ataxia and confusion in elderly
general indication for barbiturates
+MOA
sedation for critically ill patients and occasionally for refractory seizures
modulate GABA-A receptors to keep it open–> CNS depression
which barbiutate only lasts 5-10 minutes because it is redistributed quickly to sk M and fat
thiopental
AEs of thiopental
myocardial depression arrhythmia somnolence cough/sneeze bronchospasm/laryngospasm shivering
indication and contraindication for secobarbital
ind= insomnia and pre-anesthetic contra= respiratory ds, porphyria (dark urine, AMS, skin photophobia)
contraindications for phenobarbital
porphyria (dark urine, skin photophobia, AMS)
relative contra= mental depression, suicidal tendencies, hx of drug abuse
describe the metabolism of barbituates
= cyp450 inducers
hepatic metabolism, renal excretion
describe MOA of zolpidem, zaleplon, and eszopidone
zolpidem= GABA A1 receptor modulator zaleplon= GABA A1 eszopidone= GABA A1
–> CNS depression
describe use of zolpidem/zaleplon/eszopidone in elderly populations
have a higher half life in elderly so overdose can lead to cognitive impairment, delerium, impaired balance and increased falls
describe metabolism of zolpidem, zaleplon, and eszopidone
cyp450 inducer